Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EnBrace HR is a prescription, orally administered prenatal vitamin and dietary supplement formulated for women of childbearing age, especially those at high risk for pregnancy complications or with increased requirements for folate and vitamin B12. It contains a unique combination of bioactive folates (including L-methylfolate, leucovorin, and folic acid), vitamin B12 (as cobamamide), iron (as ferrous cysteine glycinate), other B vitamins (such as pyridoxal phosphate and cocarboxylase), minerals (magnesium ascorbate, zinc ascorbate), omega fatty acids in phosphatidylserine forms, betaine, magnesium L-threonate, NADH, flavin adenine dinucleotide, and additional cofactors. The formulation is designed to address deficiencies due to genetic polymorphisms like MTHFR mutations that impair normal folate metabolism. EnBrace HR is indicated for the treatment of vitamin deficiency—specifically vitamin B12 deficiency—and the prevention of cofactor deficiencies such as l-methylfolate during preconception, pregnancy, postpartum periods or in patients with increased needs due to medical conditions. It has been studied as an alternative or adjunctive therapy in perinatal depression and has demonstrated efficacy in lowering homocysteine levels associated with adverse reproductive outcomes[1][5][6][8]. The product is gluten-free but contains small amounts of fish/krill/soy; it does not provide significant amounts of magnesium or zinc[3][10]. Manufactured by JayMac Pharmaceuticals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on EnBrace HR.